Photothermal Iron‐Based Riboflavin Microneedles for the Treatment of Bacterial Keratitis via Ion Therapy and Immunomodulation
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202304448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jun Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Aier Eye Hospital, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Riboflavin, Keratitis, Iron, Immunomodulation. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Aier Eye Hospital Group Scientific Research Fund, Animal Ethical and Welfare Committee of Shanghai Aier Eye Hospital.
Abstract (Originalsprache)
Bacterial biofilm formation protects bacteria from antibiotics and the immune system, excessive inflammation further complicates treatment. Here, iron‐based metal–organic framework (MIL‐101)‐loaded riboflavin nanoparticles are designed for the therapeutic challenge of biofilm infection and hyperinflammation in bacterial keratitis. Specifically, MIL‐101 produces a thermal effect under exogenous near‐infrared light irradiation, which synergizes with ferroptosis‐like bacterial death induced by iron ions to exert an effective biofilm infection eradication effect. On the other hand, the disintegration of MIL‐101 sustains the release of riboflavin, which inhibits the pro‐inflammatory response of macrophage over‐activation by modulating their phenotypic switch. In addition, to solve the problems of short residence time, poor permeability, and low bioavailability of corneal medication, the MR@MN microneedle patch is further prepared by loading nanoparticles into SilMA hydrogel, which ultimately achieves painless, transepithelial, and highly efficient drug delivery. In vivo and ex vivo experiments demonstrate the effectiveness of this approach in eliminating bacterial infection and promoting corneal healing. Therefore, the MRMN patch, acting as an ocular drug delivery system with the ability of rapid corneal healing, promises a cost‐effective solution for the treatment of bacterial keratitis, which may also lead to a new approach for treating bacterial keratitis in clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai Aier Eye Hospital, Shanghai, P. R. China.
- Department of Ophthalmology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, 200233, China.
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
ORCID-Profile: Yongxiang Jiang
Förderung
- National Natural Science Foundation of China
- Aier Eye Hospital Group Scientific Research Fund
- Animal Ethical and Welfare Committee of Shanghai Aier Eye Hospital
Zitieren
APA
Zhou, J., Zhang, L., Wei, Y., Wu, Q., Mao, K., Wang, X., Cai, J., Li, X., & Jiang, Y. (2024). Photothermal Iron‐Based Riboflavin Microneedles for the Treatment of Bacterial Keratitis via Ion Therapy and Immunomodulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304448
Vancouver
Zhou J, Zhang L, Wei Y, Wu Q, Mao K, Wang X, et al. Photothermal Iron‐Based Riboflavin Microneedles for the Treatment of Bacterial Keratitis via Ion Therapy and Immunomodulation. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202304448
BibTeX
@article{Zhou2024,
author = {Zhou, Jun and Zhang, Lisha and Wei, Yaqi and Wu, Qiang and Mao, Kaibo and Wang, Xiaoli and Cai, Jinfeng and Li, Xia and Jiang, Yongxiang},
title = {Photothermal Iron‐Based Riboflavin Microneedles for the Treatment of Bacterial Keratitis via Ion Therapy and Immunomodulation},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202304448}
}
EUVIMED